Trends in Vaccination Coverage among Children Aged 2-6 Years in Tennessee Counties, 2017-2023.

Trends in Vaccination Coverage among Children Aged 2-6 Years in Tennessee Counties, 2017-2023.

Publication date: Sep 13, 2024

Background/Objectives: This study examines trends in county-level vaccination coverage before, during, and after the COVID-19 pandemic among children aged 2-3 and 4-6 years in Tennessee, with a focus on rurality; Methods: Data from the Tennessee Immunization Information System (January 2017 to September 2023) were analyzed for vaccination coverage in children in both age groups. The study categorized the COVID-19 pandemic into three periods: pre-pandemic (P1: January 2017 to December 2019), stay-at-home (P2: January 2020 to May 2021), and reopening (P3: June 2021 to September 2023). Vaccination trends were stratified by vaccine type, rurality, sex, race and ethnicity; Results: During P1, there were no significant changes in trends of vaccination coverage percentages in both rural and urban counties for both age groups. However, vaccination coverage declined significantly during P2 and P3 compared to P1 for most vaccines, except for influenza, which initially increased but later declined. Rural counties experienced a more pronounced decline compared to urban counties during P2 and P3 for both age groups. Within rural and urban counties, vaccination coverage was higher among white children compared to black children, and among non-Hispanic compared to Hispanic children. There were higher coverage percentages in age group 4-6 for all vaccines, except for influenza, compared to 2-3 year group; Conclusions: The COVID-19 pandemic has exacerbated disparities in childhood vaccination coverage, particularly in rural areas. These findings highlight the need for targeted public health interventions to address barriers to vaccination and ensure equitable access to vaccines for all children.

Open Access PDF

Concepts Keywords
Hispanic COVID-19
Influenza immunization
June pandemic
Rurality pediatrics
vaccination

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH influenza
disease MESH Emergency
disease MESH Vaccine Preventable Diseases
disease MESH infectious diseases
drug DRUGBANK Coenzyme M
disease MESH Hepatitis
disease MESH Complications
disease MESH Diphtheria
disease MESH Tetanus
disease MESH Pertussis
pathway KEGG Pertussis
disease MESH airway obstruction
disease MESH pneumonia
disease MESH respiratory failure
disease MESH death
disease MESH Spasms
disease MESH breathlessness
disease MESH chronic diseases
disease MESH jaundice
disease MESH Fulminant hepatitis
disease MESH liver cancer
disease MESH cirrhosis
disease MESH premature death
disease MESH meningitis
disease MESH Poliomyelitis
disease MESH Paralysis
disease MESH Measles
pathway KEGG Measles
disease MESH Mumps
disease MESH Rubella
disease MESH ear infections
disease MESH encephalitis
disease MESH arthritis
disease MESH hearing impairment
disease MESH birth defect
drug DRUGBANK Penciclovir
disease IDO blood
disease MESH infections
disease MESH Dehydration
disease MESH Varicella
disease MESH Hepatitis A
disease MESH Hepatitis B
pathway KEGG Hepatitis B
disease MESH respiratory diseases
disease IDO healthcare facility
disease IDO site
disease MESH social vulnerability
disease IDO susceptibility

Original Article

(Visited 2 times, 1 visits today)